Prediction of Prognosis to Concurrent Chemo-Radiotherapy by Standardized Uptake Value of ![]() |
Lee Sang-wook
(Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center)
Im Ki Chun (Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center) Nam Soon Yuhl (Department of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) Kim Jae Seung (Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center) Choi Eun Kyung (Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center) Ahn Seung Do (Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center) Shin Seong Soo (Department of Radiation Oncology, University of Ulsan College of Medicine, Asan Medical Center) Ryu Jin Sook (Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center) Kim Sang Yoon (Department of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) Lee Bong-Jae (Department of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) Choi Seung-Ho (Department of Otorhinolaryngology, University of Ulsan College of Medicine, Asan Medical Center) Kim Sung-Bae (Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center) Moon Dae Hyuk (Department of Nuclear Medicine, University of Ulsan College of Medicine, Asan Medical Center) |
1 | Wang CC, Little JB, Schulz MD. Cancer of the nasopharynx. Its clinical and radiotherapeutic considerations. Cancer 1962;15:921-926 DOI PUBMED ScienceOn |
2 | Johansen LV, Mestre M, Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck 1992;14:200-207 DOI ScienceOn |
3 | Mesic JB, Fletcher GH, Goepfert H. Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 1981;7:447-453 DOI ScienceOn |
4 | Kao CH, ChangLai SP, Chieng PU, et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography. J Clin Oncol 1998;16:3550-3555 DOI |
5 | Bailet JW, Sercarz JA, Abemayor E, et al. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients. Laryngoscope 1995;105:135-139 DOI PUBMED ScienceOn |
6 | Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relBlood flow and metabolism in locally advanced breast cancer: relationship to response to therapyationship to response to therapy. J Nucl Med 2002;43:500-509 PUBMED |
7 | Eary JF, O'Sullivan F, Powitan Y, et al. Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging 2002;29:1149-1154 DOI PUBMED ScienceOn |
8 | Kitagawa Y, Sano K, Nishizawa S, et al. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 2003;30:63-71 DOI PUBMED |
9 | Spence AM, Muzi M, Krohn KA. Molecular imaging of regional brain tumor biology. J Cell Biochem 2002;39(Suppl):25-35 DOI ScienceOn |
10 | Oshida M, Uno K, Suzuki M, et al. Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose. Cancer 1998;82:2227-2234 DOI PUBMED ScienceOn |
11 | Higashi K, Ueda Y, Yagishita M, et al. FDG PET measurement of the proliferative potential of non-small cell lung cancer. J Nucl Med 2000;41:85-92 PUBMED |
12 | Hoekstra CJ, Paglianiti I, Hoekstra OS, et al. Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods. Eur J Nucl Med 2000;27:731-743 DOI ScienceOn |
13 | Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluations with FDG. J Nucl Med 1991;32:1555-1558 |
14 | Wahl RL, Hutchins GD, Buchsbaum DJ, et al. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positronemission tomography. Cancer 1991;67:1544-1550 DOI PUBMED ScienceOn |
15 | Ho JHC. Stage classification of nasopharyngeal carcinoma: a review. In: De The G, Eto Y, editors. Nasopharyngeal carcinoma: etiology and control. IARC Scientific Pub. No. 20. Lyon: International Agency for Research on Cancer, 1978:99-113 |
16 | Perez CA, Devineni VR, Marcial-Vega V, et al. Carcinoma of the nasopharynx: factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992;23:271-280 DOI PUBMED ScienceOn |
17 | Folpe AL, Lyles RH, Sprouse JT, et al. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res 2000;6: 1279-1287 |
18 | Schulte M, Brecht-Krauss D, Heymer B, et al. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med 1999;26:599-605 DOI ScienceOn |
19 | Teo P, Tsao SY, Shiu W, et al. A clinical study of 407 cases of nasopharyngeal carcinoma in Hong Kong. Int J Radiat Oncol Biol Phys 1989;17:515-530 DOI ScienceOn |
20 | Petrovich Z, Cox JD, Middleton R, et al. Advanced carcinoma of the nasopharynx. 2. Pattern of failure in 256 patients. Radiother Oncol 1985;4:15-20 DOI ScienceOn |
21 | Terhaard CH, Bongers V, van Rijk PP, et al. F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933-941 DOI ScienceOn |
22 | Halfpenny W, Hain SF, Biassoni L, et al. FDG-PET. A possible prognostic factor in head and neck cancer. Br J Cancer 2002;86:512-516 DOI ScienceOn |
23 | Vesselle H, Schmidt RA, Pugsley JM, et al. Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 2000;6:3837-3844 |
24 | Minn H, Lapela M, Klemi PJ, et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 1997;38:1907-1911 |
25 | Kao CH, Hsieh JF, Tsai SC, et al. Comparison of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detection of cervical lymph node metastases of nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 2000;109:1130-1134 DOI PUBMED |
26 | Tsai MH, Shiau YC, Kao CH, et al. Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapy. J Cancer Res Clin Oncol 2002;128:279-282 DOI ScienceOn |
27 | Hsu MM, Huang SC, Lynn TC, et al. The survival of patients with nasopharyngeal carcinoma. Otolaryngol Head Neck Surg 1982;90:289-295 |
28 | Fleming ID, Cooper JS, Henson DE, et al. AJCC cancer staging manual 5th ed. Philadelphia; Lippincott-Raven, 1997 |
29 | Lee S, Kim JS, Ryu JS, et al. Evaluation of the response of radiotherapy to squamous cell carcinoma of the head and neck using 18FDG-PET. Kor J Head Neck Oncol 2003;19:58-62 과학기술학회마을 |
30 | Kwong D, Sham J, Choy D. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: an analysis of 1301 patients. Int J Radiat Oncol Biol Phys 1994;30:1029-1036 DOI ScienceOn |
31 | Huang SC. Anatomy of SUV. Standardized uptake value. Nucl Med Biol 2000;27:643-646 DOI PUBMED ScienceOn |
32 | Lee S, Kim GE, Suh CO, Lee KK, Park W. A Comparison of T classification of the AJCC and Ho staging systems for nasopharyngeal carcinoma. Kor J Head Neck Oncol 2002;18:179-183 과학기술학회마을 |
33 | Sakamoto H, Nakai Y, Ohashi Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngol Suppl 1998;538:254-260 DOI ScienceOn |
34 | Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-141 DOI |
35 | Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000;41:1695-1701 |
36 | Lee S, Kim JS, Im KC, et al. Change of FDG uptake according to radiation dose on squamous cell carcinoma of the head and neck. J Korean Soc Ther Radiol 2004;22:98-107 과학기술학회마을 |
37 | Lyon RC, Cohen JS, Faustino PJ, et al. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res 1988;48:870-877 PUBMED |
38 | Min H, Hong M, Ma J, et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994;30:1037-1042 DOI ScienceOn |
39 | Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-1317 DOI |
40 | Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002;24:127-135 DOI ScienceOn |
41 | Kao CH, Shiau YC, Shen YY, et al. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography. Cancer 2002;94:1981-1986 DOI PUBMED ScienceOn |
42 | Larson SM, Weiden PL, Grunbaum Z, et al. Positron imaging feasibility studies. II: characteristics of 2-deoxyglucose uptake in rodent and canine neoplasms: concise communi cation. J Nucl Med 1981;22:875-879 |
43 | Allal AS, Dulguerov P, Allaoua M, et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 2002;20:1398-1404 DOI ScienceOn |
44 | Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998;4:1215-1220 |
45 | Yang Y, Kim JS, Kim SY, et al. Comparison of 18F FDG-PET and CT/MRI for the diagnosis of cervical lymph node metastasis in head and neck cancer: a level-by-level based study. Kor J Nucl Med 2004;38:52-61 |
46 | Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23:261-270 DOI PUBMED ScienceOn |
47 | Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993;27:455-464 DOI PUBMED ScienceOn |
48 | Vansteenkiste JF, Stroobants SG, Dupont PJ, et al. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. Leuven Lung Cancer Group. J Clin Oncol 1999;17:3201-3206 DOI |
49 | Sigurdson ER CA. Commentary on 'The applications of PET in clinical oncology'. J Nucl Med 1991;32:649-650 |
50 | Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211 DOI |
51 | Ahuja V, Coleman RE, Herndon J, et al. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. Cancer 1998;83:918-924 DOI ScienceOn |
![]() |